Racura Oncology (ASX:RAC) Buyback Yield %: -2.19 (As of Jul. 01, 2026)


ASX:RAC Racura Oncology Ltd ASX:RAC
31 GF Score
Price A$2.20
View Full Analysis

What is Racura Oncology Buyback Yield %?

Racura Oncology ASX:RAC -0.90% 31 Buyback Yield % is -2.19 as of Jul. 01, 2026. GuruFocus rates ASX:RAC with a GF Score™ of 31/100. Among 745 Biotechnology companies, Racura Oncology ranks better than 68.59% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Racura Oncology's current buyback yield was -2.19%.

Racura Oncology Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Racura Oncology's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Racura Oncology Buyback Yield % Chart

Racura Oncology Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.33 -9.81 0.64 -1.68 -0.52

Racura Oncology Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.23 -1.68 -2.52 -0.52 -1.93

ASX:RAC vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, Racura Oncology's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Racura Oncology Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Racura Oncology's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Racura Oncology's Buyback Yield % falls into.


ASX:RAC
31GF Score
Racura Oncology Ltd ASX:RAC
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Racura Oncology Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Racura Oncology's Buyback Yield for the fiscal year that ended in Jun. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 1.061) / 204.1492
=-0.52%

Racura Oncology's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 9.506) / 493.63587
=-1.93%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -2.19 mean?
Racura Oncology (ASX:RAC) has a Buyback Yield % of -2.19 as of Jul. 01, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Racura Oncology and its competitors. According to the industry distribution chart, Racura Oncology ranks #234 out of 745 companies in the Biotechnology industry, placing it in the top 31.4%.
Is Racura Oncology's Buyback Yield % too high?
Racura Oncology's current Buyback Yield % is -2.19. Based on the distribution chart, Racura Oncology ranks #234 out of 745 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Racura Oncology has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Racura Oncology's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Racura Oncology ranks #234 out of 745 companies for Buyback Yield %. This puts Racura Oncology in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Racura Oncology and its competitors. Racura Oncology's current Buyback Yield % is -2.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Racura Oncology stock overvalued right now?
Racura Oncology (ASX:RAC) has a current Buyback Yield % of -2.19. The current Buyback Yield % is -2.19. Racura Oncology's overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Racura Oncology (ASX:RAC), the current Buyback Yield % is -2.19 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Racura Oncology Business Description

Other Exchanges FN3:Germany
Address 1 Macquarie Place, Level 36, Gateway, Sydney, NSW, AUS, 2000
Racura Oncology Ltd is a developer of an oncology therapeutics platform designed to develop targeted cancer treatments. The company offers precision oncology drug development, biomarker-driven research, and cancer metabolism therapies, enabling healthcare providers and cancer patients to access targeted treatment options with improved therapeutic outcomes.
31GF Score

Get the complete analysis for ASX:RAC

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.20
Price